By expenditures
| Name | Title | Type |
|---|---|---|
| Daphne Chan | Interim Head Of Finance | Auditee |
| Brent Copen | CFO | Auditee |
| Jeremy Ware | Partner | Auditee |
| Kinman Tong | Partner | Auditee |
| Robert Church | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 388651 | 2025 | 2026-02-23 | BAKER TILLY US LLP | $19.95M |
| 339437 | 2024 | 2025-01-23 | Moss Adams LLP | $19.98M |
| 296893 | 2023 | 2024-03-22 | Chw LLP | $24.95M |
| 41670 | 2022 | 2023-04-13 | Chw LLP | $25.20M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 388651 | 2025 | 2026-02-23 | 1175026 | 2025-002 | Material Weakness | Yes | B |
| 388651 | 2025 | 2026-02-23 | 1175025 | 2025-002 | Material Weakness | Yes | B |
| 388651 | 2025 | 2026-02-23 | 1175024 | 2025-002 | Material Weakness | Yes | B |
| 388651 | 2025 | 2026-02-23 | 1175023 | 2025-002 | Material Weakness | Yes | B |
| 388651 | 2025 | 2026-02-23 | 1175022 | 2025-002 | Material Weakness | Yes | B |
| 388651 | 2025 | 2026-02-23 | 1175021 | 2025-002 | Material Weakness | Yes | B |
| 388651 | 2025 | 2026-02-23 | 1175020 | 2025-002 | Material Weakness | Yes | B |
| 388651 | 2025 | 2026-02-23 | 1175019 | 2025-002 | Material Weakness | Yes | B |
| 388651 | 2025 | 2026-02-23 | 1175018 | 2025-002 | Material Weakness | Yes | B |
| 388651 | 2025 | 2026-02-23 | 1175017 | 2025-002 | Material Weakness | Yes | B |
| 388651 | 2025 | 2026-02-23 | 1175016 | 2025-002 | Material Weakness | Yes | B |
| 388651 | 2025 | 2026-02-23 | 1175015 | 2025-001 | Material Weakness | Yes | N |
| 388651 | 2025 | 2026-02-23 | 1175014 | 2025-001 | Material Weakness | Yes | N |
| 388651 | 2025 | 2026-02-23 | 1175013 | 2025-001 | Material Weakness | Yes | N |
| 388651 | 2025 | 2026-02-23 | 1175012 | 2025-001 | Material Weakness | Yes | N |
| 388651 | 2025 | 2026-02-23 | 1175011 | 2025-001 | Material Weakness | Yes | N |
| 339437 | 2024 | 2025-01-23 | 1096445 | 2024-001 | Significant Deficiency | - | N |
| 339437 | 2024 | 2025-01-23 | 1096444 | 2024-001 | Significant Deficiency | - | N |
| 339437 | 2024 | 2025-01-23 | 1096443 | 2024-001 | Significant Deficiency | - | N |
| 339437 | 2024 | 2025-01-23 | 1096442 | 2024-001 | Significant Deficiency | - | N |
| 339437 | 2024 | 2025-01-23 | 520003 | 2024-001 | Significant Deficiency | - | N |
| 339437 | 2024 | 2025-01-23 | 520002 | 2024-001 | Significant Deficiency | - | N |
| 339437 | 2024 | 2025-01-23 | 520001 | 2024-001 | Significant Deficiency | - | N |
| 339437 | 2024 | 2025-01-23 | 520000 | 2024-001 | Significant Deficiency | - | N |
| 41670 | 2022 | 2023-04-13 | 625023 | 2022-001 | Significant Deficiency | - | N |
| 41670 | 2022 | 2023-04-13 | 48581 | 2022-001 | Significant Deficiency | - | N |